AF
GMAB icon

Allworth Financial’s Genmab GMAB Stock Holding History

Allworth Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Sell
1,000
-119
-11% -$3.16K ﹤0.01% 2949
2026
Q1 		$30K Sell
1,119
-51
-4% -$1.53K ﹤0.01% 2705
2025
Q4 		$36K Buy
1,170
+45
+4% +$1.4K ﹤0.01% 2421
2025
Q3 		$34.5K Buy
1,125
+142
+14% +$3.46K ﹤0.01% 2368
2025
Q2 		$20.3K Buy
983
+259
+36% +$5.32K ﹤0.01% 2510
2025
Q1 		$14.9K Sell
724
-126
-15% -$2.64K ﹤0.01% 2243
2024
Q4 		$17.8K Buy
850
+245
+40% +$5.38K ﹤0.01% 2169
2024
Q3 		$14.8K Buy
605
+30
+5% +$802 ﹤0.01% 2094
2024
Q2 		$16K Buy
575
+29
+5% +$822 ﹤0.01% 2013
2024
Q1 		$16.3K Sell
546
-58
-10% -$1.7K ﹤0.01% 1886
2023
Q4 		$19.2K Buy
604
+254
+73% +$7.97K ﹤0.01% 1673
2023
Q3 		$12.3K Buy
350
+20
+6% +$762 ﹤0.01% 1765
2023
Q2 		$12.5K Hold
330
– – ﹤0.01% 1789
2023
Q1 		$12.5K Sell
330
-50
-13% -$1.92K ﹤0.01% 1718
2022
Q4 		$16.1K Buy
380
+10
+3% +$412 ﹤0.01% 1478
2022
Q3 		$12K Buy
370
+80
+28% +$2.81K ﹤0.01% 1543
2022
Q2 		$9K Buy
+290
New +$9.4K ﹤0.01% 1600

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Allworth Financial's GMAB Position: Q2 2026 in Review

Allworth Financial reduced its Genmab (GMAB) stake by 11% in Q2 2026, selling an estimated $3.16K and leaving 1,000 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

Allworth Financial first reported a position in GMAB in Q2 2022 and has held it in 17 quarters since. The position peaked at $36K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Allworth Financial held 1,000 shares of Genmab worth $27.5K as of Q2 2026.
  • Allworth Financial sold 119 Genmab shares in Q2 2026, an estimated $3.16K.
  • Genmab made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2949 holding.
  • Allworth Financial first reported a position in Genmab in Q2 2022 and has held it in 17 quarters since.
  • Allworth Financial's Genmab position peaked at $36K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.